SPI and SPG in the treatment of advanced malignant lesions.
D000477:Alkylating Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D009369:Neoplasms / Q000188:drug therapy*; D010243:Paralysis / Q000139:chemically induced; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011033:Podophyllin / Q000627:therapeutic use; D011035:Podophyllum / Q000627:therapeutic use*
D000477:Alkylating Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D006728:Hormones; D011033:Podophyllin